Skip to content
Screener

Pediatrix Medical Group MD Q3 2025 earnings

Reported November 3, 2025 · Before market open

Revenue$492.9MBeat by $6.6M
EPS$0.67Beat by $0.21
Revenue estimate$486.2M
EPS estimate$0.46

Next report

Nov 2, 2026 (In 2 weeks)
Revenue estimate$498.2M
EPS estimate$0.65

Financials

Q3 2025

Income statement

See full
Revenue$492.9M-3.6%
Operating income$68.1M+101%
Net income$71.7M+269%
EPS (diluted)$0.84+265%

Balance sheet

See full
Cash & equivalents$340.1M+228%
Total debt$642.3M+743%
Total equity$890.7M+21.6%
Total assets$2.2B+5.9%

Cash flow

See full
Operating cash flow$137.3M+49.5%
CapEx$5.3M-15.1%
Free cash flow$131.9M+54.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.46B+51.0%
Enterprise value$1.76B+87.7%
P/S0.8×+0.3×

Profitability

See full
FCF margin14.2%+8.5pp

Returns & leverage

See full
Debt / equity0.7×+0.6×
Current ratio1.8×+0.4×

Segments

By product

See full
Health Care Patient Service$422.2M-3.8%
Hospitals Contracts$67.7M-6.5%

FAQ

When did Pediatrix Medical Group report Q3 2025 earnings?
Pediatrix Medical Group (MD) reported Q3 2025 earnings on November 3, 2025 before market open.
What were Pediatrix Medical Group's Q3 2025 revenue and EPS?
Pediatrix Medical Group reported revenue of $492.9M and eps of $0.67 for Q3 2025.
Did Pediatrix Medical Group beat estimates in Q3 2025?
Revenue beat the consensus estimate of $486.2M by $6.6M. EPS beat the consensus estimate of $0.46 by $0.21.
How did Pediatrix Medical Group's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.6% from $511.2M a year earlier and eps grew 52.3% from $0.44.
Where can I find Pediatrix Medical Group's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-261626) and the 10-Q periodic report (0001193125-25-261640) directly on SEC EDGAR. The filing index links above go to sec.gov.